Logo image of NKLA

NIKOLA CORP (NKLA) Stock Fundamental Analysis

NASDAQ:NKLA - US6541103031 - Common Stock

0.183 USD
-0.07 (-28.74%)
Last: 2/25/2025, 8:00:01 PM
0.1859 USD
+0 (+1.58%)
After Hours: 2/25/2025, 8:00:01 PM
Fundamental Rating

2

NKLA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. Both the profitability and financial health of NKLA have multiple concerns. NKLA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year NKLA has reported negative net income.
NKLA had a negative operating cash flow in the past year.
NKLA had negative earnings in 4 of the past 5 years.
NKLA had a negative operating cash flow in each of the past 5 years.
NKLA Yearly Net Income VS EBIT VS OCF VS FCFNKLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M -800M

1.2 Ratios

NKLA has a worse Return On Assets (-61.27%) than 92.13% of its industry peers.
Looking at the Return On Equity, with a value of -167.38%, NKLA is doing worse than 89.76% of the companies in the same industry.
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROIC N/A
ROA(3y)-69.66%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.19%
ROIC(3y)N/A
ROIC(5y)N/A
NKLA Yearly ROA, ROE, ROICNKLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NKLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NKLA Yearly Profit, Operating, Gross MarginsNKLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100K -200K -300K -400K

1

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NKLA has more shares outstanding
The number of shares outstanding for NKLA has been increased compared to 5 years ago.
The debt/assets ratio for NKLA has been reduced compared to a year ago.
NKLA Yearly Shares OutstandingNKLA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NKLA Yearly Total Debt VS Total AssetsNKLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -6.37, we must say that NKLA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NKLA (-6.37) is worse than 88.19% of its industry peers.
NKLA has a Debt/Equity ratio of 0.72. This is a neutral value indicating NKLA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, NKLA is doing worse than 70.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -6.37
ROIC/WACCN/A
WACC2.73%
NKLA Yearly LT Debt VS Equity VS FCFNKLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M -500M

2.3 Liquidity

A Current Ratio of 1.17 indicates that NKLA should not have too much problems paying its short term obligations.
NKLA has a Current ratio of 1.17. This is amonst the worse of the industry: NKLA underperforms 87.40% of its industry peers.
A Quick Ratio of 0.94 indicates that NKLA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, NKLA is doing worse than 70.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.94
NKLA Yearly Current Assets VS Current LiabilitesNKLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

7

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.31%, which is quite impressive.
NKLA shows a strong growth in Revenue. In the last year, the Revenue has grown by 153.71%.
Measured over the past years, NKLA shows a very strong growth in Revenue. The Revenue has been growing by 622.57% on average per year.
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
Revenue 1Y (TTM)153.71%
Revenue growth 3Y622.57%
Revenue growth 5YN/A
Sales Q2Q%1553.87%

3.2 Future

The Earnings Per Share is expected to grow by 14.89% on average over the next years. This is quite good.
NKLA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 129.36% yearly.
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue Next Year177.15%
Revenue Next 2Y202.57%
Revenue Next 3Y139.21%
Revenue Next 5Y129.36%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NKLA Yearly Revenue VS EstimatesNKLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
NKLA Yearly EPS VS EstimatesNKLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Also next year NKLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NKLA Price Earnings VS Forward Price EarningsNKLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NKLA Per share dataNKLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

NKLA's earnings are expected to grow with 21.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.61%
EPS Next 3Y21.07%

0

5. Dividend

5.1 Amount

NKLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (2/25/2025, 8:00:01 PM)

After market: 0.1859 +0 (+1.58%)

0.183

-0.07 (-28.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners41.32%
Inst Owner Change-2.78%
Ins Owners0.67%
Ins Owner Change0%
Market Cap15.46M
Analysts43.33
Price Target4.08 (2129.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.26%
Min EPS beat(2)-20.58%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-20.58%
Max EPS beat(4)17.04%
EPS beat(8)6
Avg EPS beat(8)-8.62%
EPS beat(12)10
Avg EPS beat(12)2.34%
EPS beat(16)14
Avg EPS beat(16)10.04%
Revenue beat(2)1
Avg Revenue beat(2)-10.23%
Min Revenue beat(2)-33.69%
Max Revenue beat(2)13.22%
Revenue beat(4)1
Avg Revenue beat(4)-21.12%
Min Revenue beat(4)-53.46%
Max Revenue beat(4)13.22%
Revenue beat(8)1
Avg Revenue beat(8)-37.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-27.27%
EPS NQ rev (1m)-30.46%
EPS NQ rev (3m)-10.59%
EPS NY rev (1m)0%
EPS NY rev (3m)9.31%
Revenue NQ rev (1m)9.46%
Revenue NQ rev (3m)5.84%
Revenue NY rev (1m)-3.9%
Revenue NY rev (3m)-3.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB 0.05
EV/EBITDA N/A
EPS(TTM)-11.42
EYN/A
EPS(NY)-6.99
Fwd EYN/A
FCF(TTM)-6.79
FCFYN/A
OCF(TTM)-6.12
OCFYN/A
SpS0.89
BVpS4.49
TBVpS3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.27%
ROE -167.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.66%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 137.76%
Cap/Sales 73.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.94
Altman-Z -6.37
F-Score4
WACC2.73%
ROIC/WACCN/A
Cap/Depr(3y)1084.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.44%
EPS Next Y59.84%
EPS Next 2Y31.61%
EPS Next 3Y21.07%
EPS Next 5Y14.89%
Revenue 1Y (TTM)153.71%
Revenue growth 3Y622.57%
Revenue growth 5YN/A
Sales Q2Q%1553.87%
Revenue Next Year177.15%
Revenue Next 2Y202.57%
Revenue Next 3Y139.21%
Revenue Next 5Y129.36%
EBIT growth 1Y17.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.66%
EBIT Next 3Y19.66%
EBIT Next 5Y25.05%
FCF growth 1Y21.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.78%
OCF growth 3YN/A
OCF growth 5YN/A